| 4408 |
Selection of Monitoring Methods by Type of Digital Technology |
06/06/2024 |
Surveillance, SM&E and Epidemiology |
| 4407 |
Selection of Monitoring Methods by Type of Patient |
06/06/2024 |
Surveillance, SM&E and Epidemiology |
| 4413 |
Adherence Intervention |
06/06/2024 |
Surveillance, SM&E and Epidemiology |
| 4472 |
Presumptive TB Examination Rate |
06/06/2024 |
Surveillance, SM&E and Epidemiology |
| 4486 |
Community based death review |
06/06/2024 |
Surveillance, SM&E and Epidemiology |
| 4487 |
Facility-based mortality audit [FBMA] |
06/06/2024 |
Surveillance, SM&E and Epidemiology |
| 4510 |
Limit concept |
06/06/2024 |
Surveillance, SM&E and Epidemiology |
| 4566 |
Monitoring indicators for case finding |
06/06/2024 |
Surveillance, SM&E and Epidemiology |
| 4567 |
Monitoring indicators related to Notification |
06/06/2024 |
Surveillance, SM&E and Epidemiology |
| 4568 |
Monitoring indicators related to UDST |
06/06/2024 |
Surveillance, SM&E and Epidemiology |
| 4569 |
Monitoring indicators related to ACF |
06/06/2024 |
Surveillance, SM&E and Epidemiology |
| 4727 |
Community-Based Assessment Checklist [CBAC] Form for Early Detection of NCDs and Tuberculosis |
06/06/2024 |
Surveillance, SM&E and Epidemiology |
| 4803 |
Monitoring indicators related to TB Treatment |
06/06/2024 |
Surveillance, SM&E and Epidemiology |
| 4804 |
Monitoring indicators related to DR-TB Treatment |
06/06/2024 |
Surveillance, SM&E and Epidemiology |
| 4807 |
Monitoring indicator for TB Treatment outcome |
06/06/2024 |
Surveillance, SM&E and Epidemiology |
| 4809 |
Monitoring indicators related to Adherence |
06/06/2024 |
Surveillance, SM&E and Epidemiology |
| 4811 |
Monitoring of indicators related to TB-HIV |
06/06/2024 |
Surveillance, SM&E and Epidemiology |
| 4813 |
Monitoring of indicators related to TB-HIV Treatment |
06/06/2024 |
Surveillance, SM&E and Epidemiology |
| 4815 |
Monitoring of indicators related to TB-HIV prevention |
06/06/2024 |
Surveillance, SM&E and Epidemiology |
| 4817 |
Monitoring of Tobacco usage in TB patients |
06/06/2024 |
Surveillance, SM&E and Epidemiology |
| 4819 |
Monitoring of indicators related to DBT |
06/06/2024 |
Surveillance, SM&E and Epidemiology |
| 4834 |
General Process of Supervision |
06/06/2024 |
Surveillance, SM&E and Epidemiology |
| 4835 |
Pre-requisites for Supervision |
06/06/2024 |
Surveillance, SM&E and Epidemiology |
| 4836 |
Planning for Supervisory visit |
06/06/2024 |
Surveillance, SM&E and Epidemiology |
| 4837 |
Guidelines for Selection of area/health facility for Supervision |
06/06/2024 |
Surveillance, SM&E and Epidemiology |
| 4838 |
Modalities of Supervision |
06/06/2024 |
Surveillance, SM&E and Epidemiology |
| 4840 |
Supervisory tools and checklist |
06/06/2024 |
Surveillance, SM&E and Epidemiology |
| 4868 |
Sub-national Certification |
06/06/2024 |
Surveillance, SM&E and Epidemiology |
| 4869 |
Level of monitoring |
06/06/2024 |
Surveillance, SM&E and Epidemiology |
| 4870 |
Protocol for review meetings |
06/06/2024 |
Surveillance, SM&E and Epidemiology |
